BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $117.09M in the quarter ending September 30, 2024, with 34.98% growth. This brings the company's revenue in the last twelve months to $412.58M, up 29.92% year-over-year. In the year 2023, BioCryst Pharmaceuticals had annual revenue of $331.41M with 22.37% growth.

• Revenue (ttm): $412.58M
• Revenue Growth: +29.92%
• P/S Ratio: 3.77
• Revenue / Employee: $769,737
• Employees: 536
• Market Cap: 1.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%
Dec 31, 2019	48.84M	28.18M	136.45%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.